Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
115.04 -0.97 / -0.84%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
115.10 +0.06 / +0.05%
 
Volume: 82.8K
Express Scripts Reports Public Exchange Pharmacy Trends - Analyst Blog
3:28pm / Zacks.com
Agios Doses First Patient with AG-881 in Early-Stage Study - Analyst Blog
Jun 25 / Zacks.com
Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
12:57pm / TheStreet.com
Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog
Jun 25 / Zacks.com
Gilead Submits Marketing Application for HIV Drug to FDA - Analyst Blog
10:48am / Zacks.com
Transition Therapeutics Tanks on Alzheimer's Disease Data - Analyst Blog
Jun 25 / Zacks.com
Stock Market News for July 01, 2015 - Market News
Jul 01 / Zacks.com
Genomic's Oncotype DCIS Score Betters Treatment Guidance - Analyst Blog
Jun 25 / Zacks.com
S&P 500: at what price growth?
Jul 01 / FT.com
Alnylam Reports Encouraging New Data on Hemophilia Drug - Analyst Blog
Jun 24 / Zacks.com
10 Best S&P 500 Health Care Stocks
Jul 01 / TheStreet.com
Synergy Pharmaceuticals' Plecanatide in 2nd IBS-C study - Analyst Blog
Jun 24 / Zacks.com
Is Gilead Just the First Biotech Stock to Sink?
Jul 01 / TheStreet.com
Vanda Pharmaceuticals' Schizophrenia Drug Shows Success - Analyst Blog
Jun 24 / Zacks.com
Fast Money Picks For July 1
Jul 01 / Benzinga
Pfizer Starts Phase III Rivipansel Study, GlycoMimetics Up - Analyst Blog
Jun 24 / Zacks.com
Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnio...
Jul 01 / TheStreet.com
Macrocure (MCUR) Falls: Stock Goes Down 10% - Tale of the Tape
Jun 24 / Zacks.com
'Fast Money' Recap: Greece's Uncertain Future Extends to U.S. Stocks
Jul 01 / TheStreet.com
Pfizer to Buy Two Meningitis Vaccines from Glaxo for $130M - Analyst Blog
Jun 23 / Zacks.com
3 Drugs Stocks Driving The Industry Higher
Jun 30 / TheStreet.com
The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod - Analyst Blog
Jun 23 / Zacks.com
Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog
Jun 30 / Zacks.com
Vical's Genital Herpes Vaccine Fails in Phase I/II Study - Analyst Blog
Jun 23 / Zacks.com
Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog
Jun 30 / Zacks.com
Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog
Jun 23 / Zacks.com
BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog
Jun 30 / Zacks.com
Stock Market News for June 23, 2015 - Market News
Jun 23 / Zacks.com
Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog
Jun 30 / Zacks.com
Kite Pharma and Bluebird Tie Up for HPV Cancer Targets - Analyst Blog
Jun 23 / Zacks.com
Integra to Acquire TEI, Expand in Regenerative Wound Care - Analyst Blog
Jun 30 / Zacks.com
Can a Growth Stock Also Be a Value Stock?
Jun 23 / MotleyFool.com
Juno-Celgene in Immunotherapy Deal, Initial Deal Value $1B - Analyst Blog
Jun 30 / Zacks.com
Bristol-Myers' (BMY) Melanoma Drug Opdivo Gets EU Nod - Analyst Blog
Jun 22 / Zacks.com
Stock Market News for June 30, 2015 - Market News
Jun 30 / Zacks.com
Gilead Patent for Sovaldi Rejected in China, Shares Down - Analyst Blog
Jun 22 / Zacks.com
Celgene places $1bn bet on Juno Therapeutics
Jun 29 / FT.com
Epizyme Lead Candidate Effective in Ongoing Cancer Study - Analyst Blog
Jun 22 / Zacks.com
Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog
Jun 29 / Zacks.com
Did China Just Crush Gilead Sciences' Dreams?
Jun 21 / MotleyFool.com
Gilead Sciences (GILD) Stock Declines on Lawsuit Seeking Access to Clinical Trial Dat...
Jun 29 / TheStreet.com
The Best Return on Equity in Biotech
Jun 20 / MotleyFool.com
3 Stocks to Buy if Biotech Crashes
Jun 29 / MotleyFool.com
BioMarin Pharmaceutical Surges on Price Target Increase - Analyst Blog
Jun 19 / Zacks.com
Better Dividend Stock: AbbVie or Johnson & Johnson?
Jun 29 / MotleyFool.com
Qiagen, Hitachi High-Technologies Ink Molecular Testing Deal - Analyst Blog
Jun 19 / Zacks.com
BioMarin DMD Drug Drisapersen Validated for EU Review - Analyst Blog
Jun 26 / Zacks.com
Stock Market News for June 19, 2015 - Market News
Jun 19 / Zacks.com
Eli Lilly Wins Alimta Patent Lawsuit in the UK, Shares Up - Analyst Blog
Jun 26 / Zacks.com
New heart drugs set to add billions to US healthcare bill
Jun 09 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account